Recurrent Breast Cancer


Afinitor Provides Benefit in Advanced, HER2-Positive Breast Cancer (06-28-2013)

Among women with advanced HER2-positive breast cancer and resistance to Herceptin® (trastuzumab), a treatment regimen that included Afinitor® (everolimus) delayed cancer progression. The results of this Phase III clinical trial were presented at the... Continue Reading

Effexor Preferred over Neurontin for Hot Flashes Among Breast Cancer Survivors (12-2-2010)

Women with a history of breast cancer appear to prefer the antidepressant Effexor® (venlafaxine) over the antiseizure drug Neurontin® (gabapentin) for treatment of hot flashes. These findings were recently released in the Journal of Clinical Oncology. Hot... Continue Reading

Number of Circulating Cancer Cells Associated with Survival in Advanced Breast Cancer (10-30-2008)

Number of Circulating Cancer Cells Associated with Survival in Advanced Breast Cancer Cancer cells found circulating in the blood are a strong predictor of mortality among patients with metastatic breast cancer. Patients with large numbers of cancer... Continue Reading

Nexavar® May Overcome Resistance to Arimidex® in Breast Cancer (10-8-2008)

Nexavar® May Overcome Resistance to Arimidex® in Breast Cancer The addition of Nexavar® (sorafenib) to Arimidex® (anastrozole) helps restore sensitivity to Arimidex among women with breast cancer. These results were recently presented at the 2008... Continue Reading

Continuous Low-dose Chemotherapy Effective Against Anthracycline-resistant Breast Cancer (09-26-2008)

Continuous Low-dose Chemotherapy Effective Against Anthracycline-resistant Breast Cancer The use of low-dose Taxotere? (docetaxel) on a weekly basis plus Xeloda? (capecitabine) on a daily basis provided benefit for a significant portion of patients with... Continue Reading